By Jessica Donati Feb 18 (Reuters) - Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving ...
The health trial by researchers at the University of Southern Denmark has been suspended by Bissau-Guinean authorities.
The World Health Organization (WHO) underscores that the hepatitis B birth dose vaccine is an effective, and essential public health intervention, with a proven record. It prevents life‑threatening ...
The World Health Organization on Friday voiced serious concerns over a planned US-funded hepatitis B vaccine trial on newborn ...
The U.S. Centers for Disease Control and Prevention (CDC) approved a $1.6 million grant to fund a study on the efficacy of the hepatitis B vaccine Dec. 15, 2025. After U.S. Secretary of Health ...
African scientists have criticised a study of hepatitis B virus birth dose vaccination as being unethical. Gilbert Nakweya reports.
Hosted on MSN
Guinea-Bissau counts votes as president seeks second term and main opposition party is barred
BISSAU, Guinea-Bissau (AP) — Counting of votes is underway in Guinea-Bissau where voting for presidential and legislative seats took place on Sunday for President Umaro Sissoco Embaló who is seeking a ...
Military officials in the small West African nation of Guinea-Bissau have announced a new leader one day after seizing power in a military coup. General Horta Nta Na Man was named as the head of a one ...
Guinea Bissau Army general Horta N’Tam looks on during the swearing in ceremony as the transition leader and the leader of the High Command in Bissau on November 27, 2025. The military junta in Guinea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results